Delivery Order 36F79718D0509-36C24924N0675

Award Date 9/13/24
Potential Completion Date 9/20/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Murfreesboro, TN 37129, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Welireg (belzutifan) 40mg tablets. The $176,411.12 firm fixed price award was made by the Veterans Integrated Service Network 20 (VISN 20), a division of the U.S. Department of Veterans Affairs. The contract is a delivery order issued under the General Services Administration's Federal Supply Schedule 61 for Pharmaceuticals and Drugs. The award does not have a set-aside designation. The prime contractor is Merck...
This federal contract award is for the delivery of Belzutifan (Welireg) 40 mg, a pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer and supplier to the federal government. The contract is a Delivery Order under Merck's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. It has a firm fixed price of $19,964.86 and a completion date of...
The U.S. Department of Veterans Affairs (VA) awarded a Delivery Order contract to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer, for the supply of Welireg (belzutifan) 40mg tablets. The contract has a ceiling value of $19,964.86 and a completion date of January 30, 2025. The contract was awarded on December 30, 2024 and does not have a set-aside designation. Merck holds an Indefinite Delivery Vehicle (IDV) Blanket Purchase Agreement with the VA for...
This federal contract award to Merck Sharp & Dohme LLC, doing business as Merck, is for the delivery of BELZUTIFAN 40 MG, a pharmaceutical product. The $19,964.86 Firm Fixed Price delivery order was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The contract has no set-aside designation and is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. Merck is a for-profit manufacturer of goods that...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency, to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer. The contract is for the supply of Belzutifan (Welireg) 40 mg, a cancer drug. The contract has a ceiling value of $22,051.39 and a completion date of June 27, 2025. This contract award is not associated with a set-aside designation. Merck is a significant supplier to the...
The Department of Veterans Affairs Veterans Health Administration awarded a $19,964.86 firm-fixed-price delivery order contract to Merck Sharp & Dohme LLC, doing business as Merck, for the pharmaceutical drug Welireg (Belzutifan) 40mg tablets. This award is under Merck's existing General Services Administration Federal Supply Schedule (FSS-61-IB) contract for pharmaceuticals and drugs. The contract has a completion date of June 7, 2024. Merck is a major pharmaceutical manufacturer that has...
This is a federal contract award issued by the Veterans Integrated Service Network 5 (VISN 5) of the Department of Veterans Affairs (VA) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract is for the supply of the drug WINREVAIR 45 MG under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The fixed-price delivery order has a ceiling value of $10,496.92 and a period of performance ending on April 30, 2025. The contract...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The order is for the drug Welireg (belzutifan) 40mg tablets, National Drug Code 00006-5331-01. The award has a ceiling value of $19,964.86 and an ultimate completion date of July 10, 2024. This delivery order falls under Merck's prime contract on the...
Merck Sharp & Dohme LLC, doing business as Merck, has been awarded a $139,754.02 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The order is for the provision of Welireg to meet veteran patient needs through September 6, 2024. Welireg will be delivered to the place of performance in Carrollton, Texas under firm fixed price terms. No set-aside...
This is a $10,496.92 firm fixed-price delivery order awarded by the Veterans Integrated Service Network 5 of the Department of Veterans Affairs to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The award is for the product "WINREVAIR 45 MG" and has a completion date of June 24, 2025. The contract is not associated with a set-aside designation. Merck holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including...

This federal contract award is for SOTATERCEPT - EMERGENCY, a delivery order with a ceiling value of $10,627.51, awarded to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer. The contract is a Firm Fixed Price type, under Merck's Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs. The award was made by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency within the Department of Veterans Affairs.

The contract does not have a set-aside designation. Merck is a for-profit organization and manufacturer of goods that has established itself as a critical partner in supplying essential pharmaceutical products to meet the diverse needs of government healthcare programs. Merck holds several significant indefinite delivery vehicles (IDVs) with federal agencies, primarily focused on vaccine supply and related services, with potential values ranging from $69 million to over $4 billion. The company also has a Blanket Purchase Agreement with the Department of Veterans Affairs for the supply of the drug Welireg, with a $15 million ceiling.

Generated 9/24/24, 9:07 AM